KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • Novartis Ag's Non-Current Deferred Tax Liability rose 4042.99% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 4042.99%. This contributed to the annual value of $3.4 billion for FY2025, which is 4042.99% up from last year.
  • Novartis Ag's Non-Current Deferred Tax Liability amounted to $3.4 billion in Q4 2025, which was up 4042.99% from $2.2 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Non-Current Deferred Tax Liability high stood at $7.5 billion for Q2 2021, and its period low was -$276.0 million during Q1 2022.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $2.5 billion (2023), whereas its average is $2.6 billion.
  • In the last 5 years, Novartis Ag's Non-Current Deferred Tax Liability tumbled by 79032.26% in 2022 and then soared by 108804.35% in 2023.
  • Novartis Ag's Non-Current Deferred Tax Liability (Quarter) stood at $3.1 billion in 2021, then fell by 12.51% to $2.7 billion in 2022, then fell by 16.31% to $2.2 billion in 2023, then rose by 7.61% to $2.4 billion in 2024, then skyrocketed by 40.43% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q4 2025, $2.2 billion for Q3 2025, and $2.3 billion during Q2 2025.